Company intelligence / Profile preview

CK Hutchison Holdings

Ownership: Private
Employees: ~300000
Development stage: Other

Overview

CK Hutchison Holdings is one of Asia’s largest multinational conglomerates with core businesses spanning ports/logistics, retail (including health & beauty), infrastructure (energy/water/waste), telecommunications, and finance/investments. It operates in over 50 countries with more than 300,000 employees worldwide. In life sciences/biotech/pharma specifically, it holds a significant stake in HUTCHMED—a global biopharmaceutical company focused on oncology and immunology—which achieved FDA approval for fruquintinib to treat metastatic colorectal cancer in the US through partner Takeda.

Industry: Investors

Partnerships

HutchMed partnership/licensing deal with Takeda Pharmaceutical Co.

Beyond the preview

Go deeper on CK Hutchison Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CK Hutchison Holdings.